Skip to main content

Want a detailed portfolio tracker?

Merck (MRK) P/B (1999 - 2026)

Merck (MRK) P/B from Nov 1, 1999 to Jul 20, 2026. The TTM Merck (MRK) P/B is 6.40. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/B

Annual P/B change of Merck (MRK)

YearP/BChange
20266.40+34.27%
20254.76-8.28%
20245.19-18.83%
20236.40+6.08%
20226.03+24.49%
20214.85-37.86%
20207.80-9.01%
20198.57+17.88%
20187.27+89.88%
20173.83+7.82%
20163.55+11.85%
20153.17-1.01%
20143.21+14.17%
20132.81+25.20%
20122.24+12.02%
20112.00+2.89%
20101.95+42.34%
20091.37-78.96%
20086.50+127.95%
20072.85+33.28%
20062.14+37.06%
20051.56-1.03%
20041.58-30.43%
20032.27-18.39%
20022.78-3.72%
20012.88-37.20%
20004.59+39.35%
19993.30N/A

Comparison Merck (MRK) P/B with competitors

Merck (MRK) P/B is 6.40.

TickerNameP/BUpside
AMRNAmarin Corp0.68-89.31%
GRFSGrifols SA0.79-87.65%
SNYSanofi1.27-80.14%
BIIBBiogen Inc1.52-76.25%
PFEPfizer Inc1.55-75.80%
OGNOrganon & Company3.93-38.62%
MIRAMira Pharmaceuticals Inc4.09-36.04%
GSKGSK Plc4.37-31.64%
BMYBristol-Myers Squibb Company6.04-5.56%
AZNAstrazeneca plc6.20-3.06%
GILDGilead Sciences Inc6.94+8.51%
NVONovo Nordisk7.07+10.54%
NVSNovartis AG7.60+18.83%
JNJJohnson & Johnson7.64+19.45%
NSRXNasus Pharma Ltd12.90+101.69%
MDCXMDCorp15.34+139.84%
AMGNAMGEN Inc21.17+230.99%
SCLXScilex Holding Company28.85+351.07%
LLYLilly(Eli) & Company32.94+415.02%
ABBVAbbvie Inc50.46+688.94%